217 related articles for article (PubMed ID: 34445673)
1. The Role of Mutant p63 in Female Fertility.
Luan Y; Xu P; Yu SY; Kim SY
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445673
[TBL] [Abstract][Full Text] [Related]
2. The p63 C-terminus is essential for murine oocyte integrity.
Lena AM; Rossi V; Osterburg S; Smirnov A; Osterburg C; Tuppi M; Cappello A; Amelio I; Dötsch V; De Felici M; Klinger FG; Annicchiarico-Petruzzelli M; Valensise H; Melino G; Candi E
Nat Commun; 2021 Jan; 12(1):383. PubMed ID: 33452256
[TBL] [Abstract][Full Text] [Related]
3. p63 null mutation protects mouse oocytes from radio-induced apoptosis.
Livera G; Petre-Lazar B; Guerquin MJ; Trautmann E; Coffigny H; Habert R
Reproduction; 2008 Jan; 135(1):3-12. PubMed ID: 18159078
[TBL] [Abstract][Full Text] [Related]
4. p63 the guardian of human reproduction.
Amelio I; Grespi F; Annicchiarico-Petruzzelli M; Melino G
Cell Cycle; 2012 Dec; 11(24):4545-51. PubMed ID: 23165243
[TBL] [Abstract][Full Text] [Related]
5. DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa.
Kerr JB; Hutt KJ; Michalak EM; Cook M; Vandenberg CJ; Liew SH; Bouillet P; Mills A; Scott CL; Findlay JK; Strasser A
Mol Cell; 2012 Nov; 48(3):343-52. PubMed ID: 23000175
[TBL] [Abstract][Full Text] [Related]
6. Oocyte-specific inactivation of Omcg1 leads to DNA damage and c-Abl/TAp63-dependent oocyte death associated with dramatic remodeling of ovarian somatic cells.
Vandormael-Pournin S; Guigon CJ; Ishaq M; Coudouel N; Avé P; Huerre M; Magre S; Cohen-Tannoudji J; Cohen-Tannoudji M
Cell Death Differ; 2015 Jan; 22(1):108-17. PubMed ID: 25168238
[TBL] [Abstract][Full Text] [Related]
7. Dominant TP63 missense variants lead to constitutive activation and premature ovarian insufficiency.
Tucker EJ; Gutfreund N; Belaud-Rotureau MA; Gilot D; Brun T; Kline BL; Bell KM; Domin-Bernhard M; Théard C; Touraine P; Robevska G; van van den Bergen J; Ayers KL; Sinclair AH; Dötsch V; Jaillard S
Hum Mutat; 2022 Oct; 43(10):1443-1453. PubMed ID: 35801529
[TBL] [Abstract][Full Text] [Related]
8. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
[TBL] [Abstract][Full Text] [Related]
9. Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes.
Beyer U; Moll-Rocek J; Moll UM; Dobbelstein M
Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3624-9. PubMed ID: 21300884
[TBL] [Abstract][Full Text] [Related]
10. TAp63 and DeltaNp63 in cancer and epidermal development.
Candi E; Dinsdale D; Rufini A; Salomoni P; Knight RA; Mueller M; Krammer PH; Melino G
Cell Cycle; 2007 Feb; 6(3):274-85. PubMed ID: 17264681
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of p63 isoforms in female reproductive organs.
Kurita T; Cunha GR; Robboy SJ; Mills AA; Medina RT
Mech Dev; 2005 Sep; 122(9):1043-55. PubMed ID: 15922574
[TBL] [Abstract][Full Text] [Related]
12. DNA-binding and transactivation activities are essential for TAp63 protein degradation.
Ying H; Chang DL; Zheng H; McKeon F; Xiao ZX
Mol Cell Biol; 2005 Jul; 25(14):6154-64. PubMed ID: 15988026
[TBL] [Abstract][Full Text] [Related]
13. The role of p63 in epidermal morphogenesis and neoplasia.
McDade SS; McCance DJ
Biochem Soc Trans; 2010 Feb; 38(Pt 1):223-8. PubMed ID: 20074064
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous TP63 pathogenic variants in isolated primary ovarian insufficiency.
Vanderschelden RK; Rodriguez-Escriba M; Chan SH; Berman AJ; Rajkovic A; Yatsenko SA
J Assist Reprod Genet; 2023 Sep; 40(9):2211-2218. PubMed ID: 37453019
[TBL] [Abstract][Full Text] [Related]
15. P63 in health and cancer.
Gonfloni S; Caputo V; Iannizzotto V
Int J Dev Biol; 2015; 59(1-3):87-93. PubMed ID: 26374530
[TBL] [Abstract][Full Text] [Related]
16. [The two faces of p63, Janus of the p53 gene family].
Caron de Fromentel C; Aberdam E; Aberdam D
Med Sci (Paris); 2012 Apr; 28(4):381-7. PubMed ID: 22549865
[TBL] [Abstract][Full Text] [Related]
17. Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression.
Karni-Schmidt O; Castillo-Martin M; Shen TH; Gladoun N; Domingo-Domenech J; Sanchez-Carbayo M; Li Y; Lowe S; Prives C; Cordon-Cardo C
Am J Pathol; 2011 Mar; 178(3):1350-60. PubMed ID: 21356385
[TBL] [Abstract][Full Text] [Related]
18. Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes.
Abbas HA; Bui NHB; Rajapakshe K; Wong J; Gunaratne P; Tsai KY; Coarfa C; Flores ER
Cancer Res; 2018 Jan; 78(2):451-462. PubMed ID: 29180475
[TBL] [Abstract][Full Text] [Related]
19. One, two, three--p53, p63, p73 and chemosensitivity.
Müller M; Schleithoff ES; Stremmel W; Melino G; Krammer PH; Schilling T
Drug Resist Updat; 2006 Dec; 9(6):288-306. PubMed ID: 17287142
[TBL] [Abstract][Full Text] [Related]
20. The carboxy-terminus of p63 links cell cycle control and the proliferative potential of epidermal progenitor cells.
Suzuki D; Sahu R; Leu NA; Senoo M
Development; 2015 Jan; 142(2):282-90. PubMed ID: 25503409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
